This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 05/28/2020
Location: Teleconference
Subject: Gates Foundation: Vaccine Development
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Several Gates Foundation staff

Event Date: 05/29/2020
Location: Teleconference
Subject: COVID-19 Vaccines
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several industry groups affiliated with Pharmaceutical Research and Manufacturers of America (PhRMA) and Biotechnology Innovation Organization (BIO)

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 05/28/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, providers, industry, academia, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 05/29/2020
Location: Virtual
Subject: Produce Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from the produce industry and trade associations

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 05/27/2020
Location: WebEx
Subject: COVID-19 Temporary Ingredient Labeling Guidance
FDA Participant/Group: DANIELLE SCHOR; LAURA CARROLL; CLAUDINE KAVANAUGH; KARI BARRETT; PATRICIA HANSEN;
Non FDA Participant/Group: Donna Garran, Jeannie Shaughnessy, Lee Sanders (Food and Beverage Issue Alliance (FBIA));

Event Date: 05/28/2020
Location: WebEx
Subject: COVID-19 Temporary Ingredient Labeling Guidance
FDA Participant/Group: LYNN SZYBIST; DANIELLE SCHOR; CLAUDINE KAVANAUGH; EMILY ROSE CAREY; STEFANO LUCCIOLI; JENNIFER DOOREN; LAURA CARROLL; PATRICIA HANSEN;
Non FDA Participant/Group: Jason Linde, Lisa Gable, Steve Danon (Food Allergy Research and Education (FARE));

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event